Domov › Debelost › Georgia › Johns Creek

Klinične študije za Debelost v Johns Creek, GA

16 študij za Debelost išče udeležence na lokacijah v Johns Creek in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Vključevanje udeležencevFaza 3

Eastside Bariatric and Gen Surg, Snellville · 16 mi stran

Starost 8–18 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07253285

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Vključevanje udeležencevFaza 3

Eastside Bariatric and Gen Surg, Snellville · 16 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07668414

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Vključevanje udeležencevFaza 3

Teak Research Consults, Lawrenceville · 13 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Vključevanje udeležencevFaza 3

Teak Research Consults, Lawrenceville · 13 mi stran
EBGS Clinical Research Center, Snellville · 16 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07369011

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Vključevanje udeležencevFaza 3

Teak Research Consults, Lawrenceville · 13 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07321886

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Vključevanje udeležencevFaza 2

Balanced Life Health Care Solutions/SKYCRNG, Lawrenceville · 13 mi stran
Physicians Research Associates, Lawrenceville · 13 mi stran

Starost 18–75 · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT06897475

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Vključevanje udeležencevFaza 3

Physicians Research Associates, Lawrenceville · 13 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07571005

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Vključevanje udeležencevFaza 3Vabljeni zdravi prostovoljci

ACCOMPLISH-2 Research Site, Lawrenceville · 13 mi stran

Starost 18–79 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07654374

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Vključevanje udeležencevFaza 3

Physicians Research Associates, Lawrenceville · 13 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07571109

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Vključevanje udeležencevFaza 2

Teak Research Consults, Lawrenceville · 13 mi stran

Starost 18–75 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT07215559

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Vključevanje udeležencevFaza 3

Kailera Clinical Site, Lilburn · 10 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07284901

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Vključevanje udeležencevFaza 3

Kailera Clinical Site, Lilburn · 10 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07284875

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Vključevanje udeležencevFaza 3

Nsc Research, Johns Creek

Starost 18–99 · Vsi spoli · Posodobljeno 27. avg. 2026 · NCT07575399

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Vključevanje udeležencevFaza 3

NSC Research, Inc, Johns Creek

Starost 18 in več · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Vključevanje udeležencevFaza 3

ACCOMPLISH-1 Research Site, Buford · 13 mi stran
ACCOMPLISH-1 Research Site, Lawrenceville · 13 mi stran

Starost 18–79 · Vsi spoli · Posodobljeno 10. avg. 2026 · NCT07654361

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

Vključevanje udeležencevFaza 2

Balanced Life Health Care Solutions, Lawrenceville · 13 mi stran

Starost 18–80 · Vsi spoli · Posodobljeno 22. jul. 2026 · NCT07477704

Študije za Debelost v drugih mestih

Druge študije v Johns Creek

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.